-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Iptacopan Hydrochloride in Proteinuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Iptacopan Hydrochloride in Proteinuria report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Iptacopan Hydrochloride in Proteinuria Drug Details: Iptacopan hydrochloride (Fabhalta) is a factor B...
-
Product Insights
Upper Limb Muscle Spasticity – Drugs In Development, 2023
Global Markets Direct’s, ‘Upper Limb Muscle Spasticity - Drugs In Development, 2023’, provides an overview of the Upper Limb Muscle Spasticity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Upper Limb Muscle Spasticity, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Muscle Spasticity – Drugs In Development, 2023
Global Markets Direct’s, ‘Muscle Spasticity - Drugs In Development, 2023’, provides an overview of the Muscle Spasticity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Muscle Spasticity, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pembrolizumab in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab in Pancreatic Cancer Drug Details: Pembrolizumab (Keytruda) is an antineoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-1002 in Lower Limb Muscle Spasticity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-1002 in Lower Limb Muscle Spasticity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SL-1002 in Lower Limb Muscle Spasticity Drug Details:SL-1002 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-1002 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-1002 in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SL-1002 in Osteoarthritis Pain Drug Details:SL-1002 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – APR-003 in Liver Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - APR-003 in Liver Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.APR-003 in Liver Cancer Drug Details:APR-003 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-1002 in Upper Limb Muscle Spasticity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-1002 in Upper Limb Muscle Spasticity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SL-1002 in Upper Limb Muscle SpasticityDrug Details:SL-1002 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CLN-049 in Myelodysplastic Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CLN-049 in Myelodysplastic Syndrome Drug Details:CLN-049 is under development for the treatment of relapsed or refractory...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SL-1002
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SL-1002 Drug Details SL-1002 is under development for the treatment of mild to severe...